Explore
13D/13G Activist Filings
118,856 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | BTAI | BioXcel Therapeutics, Inc. | Integrated Core Strategies (US) LLC | 13G/A | 8.4% | 1.8M |
| Feb 9, 2026 | ONDS | ONDAS HOLDINGS INC. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 4.2% | 15.3M |
| Feb 9, 2026 | DH | DEFINITIVE HEALTHCARE CORP | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 5.7% | 5.9M |
| Feb 9, 2026 | VGAS | VERDE CLEAN FUELS, INC. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 1.8% | 395K |
| Feb 9, 2026 | ABP | ABPRO HOLDINGS INC | THE GOLDMAN SACHS GROUP, INC. | 13G | 6.8% | 197K |
| Feb 9, 2026 | N/A | PEOPLES FINANCIAL CORP /MS/ | Chevis C. Swetman | 13G/A | 11.0% | 508K |
| Feb 9, 2026 | FDMT | 4D MOLECULAR THERAPEUTICS, INC. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 7.5% | 4.3M |
| Feb 9, 2026 | N/A | CBL International Ltd | Asian Strategy Ltd | 13G/A | 10.7% | 1.5M |
| Feb 9, 2026 | N/A | CBL INTERNATIONAL LIMITED | Teck Lim Chia | 13G/A | 47.9% | 13.2M |
| Feb 9, 2026 | CING | Cingulate Inc. | Falcon Creek Capital Advisor LLC | 13D | 19.9% | 2.1M |
| Feb 9, 2026 | NEGG | Newegg Commerce, Inc. | Galkin Vladimir | 13D/A | 21.0% | 4.4M |
| Feb 9, 2026 | DBD | DIEBOLD NIXDORF, Inc | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G | 5.0% | 1.8M |
| Feb 9, 2026 | RVLV | Revolve Group, Inc. | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G | 5.3% | 2.1M |
| Feb 9, 2026 | GAM-PB | General American Investors Company, Inc. | TD Asset Management Inc. | 13G/A | 0.0% | 0 |
| Feb 9, 2026 | TWST | Twist Bioscience Corp | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G/A | 9.7% | 6.0M |
| Feb 9, 2026 | FOLD | AMICUS THERAPEUTICS, INC. | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G/A | 3.4% | 10.6M |
| Feb 9, 2026 | TMCI | TREACE MEDICAL CONCEPTS, INC. | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 13G/A | 1.8% | 1.1M |
| Feb 9, 2026 | N/A | PEARSON PLC | Cevian Capital II GP LTD | 13D/A | 18.1% | 114.9M |
| Feb 9, 2026 | N/A | Cantor Equity Partners VI, Inc. | Cantor EP Holdings VI, LLC | 13D | 21.6% | 3.2M |
| Feb 9, 2026 | IAE | Voya Asia Pacific High Dividend Equity Income Fund | Saba Capital Management, L.P. | 13D/A | 15.9% | 1.7M |
| Feb 9, 2026 | KZR | Kezar Life Sciences, Inc. | BML Investment Partners, L.P. | 13G/A | 9.8% | 721K |
| Feb 9, 2026 | TIL | Instil Bio, Inc. | BML Investment Partners, L.P. | 13G/A | 9.5% | 646K |
| Feb 9, 2026 | PMVP | PMV Pharmaceuticals, Inc. | BML Investment Partners, L.P. | 13G/A | 9.9% | 5.3M |
| Feb 9, 2026 | N/A | Elemental Royalty Corp | SIM Orphan, LLC | 13G | 2.1% | 1.4M |
| Feb 9, 2026 | ORMP | ORAMED PHARMACEUTICALS INC. | BML Investment Partners, L.P. | 13G/A | 7.9% | 3.2M |
| Feb 9, 2026 | AVIR | Atea Pharmaceuticals, Inc. | BML Investment Partners, L.P. | 13G | 9.6% | 7.5M |
| Feb 9, 2026 | ACRS | Aclaris Therapeutics, Inc. | BML Investment Partners, L.P. | 13G/A | 11.9% | 14.3M |
| Feb 9, 2026 | N/A | Atlanta Braves Holdings, Inc. | John C. Malone | 13D/A | 97.1% | 949K |
| Feb 9, 2026 | BATRA | Atlanta Braves Holdings, Inc. | John C. Malone | 13D/A | 5.4% | 557K |
| Feb 9, 2026 | N/A | Silence Therapeutics plc | Lombard Odier Asset Management (USA) Corp | 13G/A | 4.2% | 5.9M |
| Feb 9, 2026 | SYM | Symbotic Inc. | BAILLIE GIFFORD & CO | 13G/A | 10.2% | 12.4M |
| Feb 9, 2026 | SQM | SOCIEDAD QUIMICA Y MINERA DE CHILE S A /FI | BAILLIE GIFFORD & CO | 13G/A | 4.4% | 6.2M |
| Feb 9, 2026 | JOBY | Joby Aviation, Inc. | BAILLIE GIFFORD & CO | 13G/A | 5.4% | 49.6M |
| Feb 9, 2026 | VCIC | VINE HILL CAPITAL INVESTMENT CORP | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 2.8% | 625K |
| Feb 9, 2026 | TRUE | TRUECAR, INC. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 2.1% | 1.9M |
| Feb 9, 2026 | COUR | Coursera, Inc. | BAILLIE GIFFORD & CO | 13G | 8.8% | 14.6M |
| Feb 9, 2026 | TNMG | TNL MEDIAGENE | THE GOLDMAN SACHS GROUP, INC. | 13G | 6.3% | 171K |
| Feb 9, 2026 | BNAI | Brand Engagement Network Inc. | THE GOLDMAN SACHS GROUP, INC. | 13G | 5.8% | 274K |
| Feb 9, 2026 | KIDZ | CLASSOVER HOLDINGS INC | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 3.7% | 928K |
| Feb 9, 2026 | AEHR | AEHR TEST SYSTEMS | BAILLIE GIFFORD & CO | 13G/A | 4.3% | 1.3M |
| Feb 9, 2026 | TTD | Trade Desk, Inc. | BAILLIE GIFFORD & CO | 13G/A | 5.1% | 22.3M |
| Feb 9, 2026 | VWAV | VisionWave Holdings, Inc. | THE GOLDMAN SACHS GROUP, INC. | 13G/A | 3.6% | 622K |
| Feb 9, 2026 | JNEU | AIM ETF Products Trust | Savant Capital, LLC | 13G | 8.6% | 75K |
| Feb 9, 2026 | MBLY | Mobileye Global Inc. | BAILLIE GIFFORD & CO | 13G/A | 3.4% | 7.4M |
| Feb 9, 2026 | PYXS | Pyxis Oncology, Inc. | Laurion Capital Management LP | 13G/A | 7.7% | 4.8M |
| Feb 9, 2026 | YETI | YETI Holdings, Inc. | BAILLIE GIFFORD & CO | 13G/A | 5.1% | 3.9M |
| Feb 9, 2026 | ENSG | ENSIGN GROUP, INC | BAILLIE GIFFORD & CO | 13G | 7.9% | 4.6M |
| Feb 9, 2026 | RELY | Remitly Global, Inc. | BAILLIE GIFFORD & CO | 13G/A | 5.6% | 11.7M |
| Feb 9, 2026 | MRNA | Moderna, Inc. | BAILLIE GIFFORD & CO | 13G/A | 5.3% | 20.6M |
| Feb 9, 2026 | N/A | PFS Bancorp, Inc. | Peru Federal Savings Bank Employee Stock Ownership Plan Trust | 13G/A | 8.6% | 138K |